Perceptions of the pharmaceutical industry and regulators in South Africa towards registration harmonisation in the Southern African Development Community (SADC)
| dc.contributor.advisor | Dube, Admire | |
| dc.contributor.advisor | Ward, Kim | |
| dc.contributor.author | Dhanraj, Keshnee | |
| dc.date.accessioned | 2021-03-09T12:52:15Z | |
| dc.date.accessioned | 2024-10-29T14:20:11Z | |
| dc.date.available | 2021-03-09T12:52:15Z | |
| dc.date.available | 2024-10-29T14:20:11Z | |
| dc.date.issued | 2021 | |
| dc.description | Magister Pharmaceuticae - MPharm | en_US |
| dc.description.abstract | Medicines have to be regulated in an effort to monitor their quality, safety, and efficacy. The process of medicines registration is lengthy, costly, and document-heavy. Many countries have limited expertise and resources at national medicines regulatory authorities (NMRAs) and some countries have adopted unified approaches to medicines registration legislation. Harmonised guidelines and initiatives have been adopted in South Africa and the Southern African Development Community (SADC). However, there are no studies that have identified the effects of these initiatives and guidelines on major stakeholders such as the pharmaceutical industry and regulators. | en_US |
| dc.identifier.uri | https://hdl.handle.net/10566/16376 | |
| dc.language.iso | en | en_US |
| dc.publisher | University of the Western Cape | en_US |
| dc.rights.holder | University of the Western Cape | en_US |
| dc.subject | Perceptions of medicines registration | en_US |
| dc.subject | Medicines registration harmonisation in SADC | en_US |
| dc.subject | Regulatory affairs | en_US |
| dc.subject | Regulators | en_US |
| dc.title | Perceptions of the pharmaceutical industry and regulators in South Africa towards registration harmonisation in the Southern African Development Community (SADC) | en_US |